NTBL

- · NASDAQ

Sector -
Industry -
Website notablelabs.com
Employees(FY) -
ISIN -

Performance

-45.43%

-62.74%

YTD

-88.05%

Profile

Notable Labs, Ltd., a clinical-stage platform therapeutics company, engages in developing predictive precision medicines for patients with cancer. The company, through its proprietary Predictive Precision Medicines Platform (PPMP), bio-simulates a cancer treatment and predicts, whether or not the patient is likely to respond to that specific therapeutic. Its PPMP is designed to identify and select clinically responsive patients prior to their treatment and thus fast-track clinical development in this patient population. The company's pipeline includes Volasertib, a potent Polo-like kinase 1 (PLK-1) inhibitor for acute myeloid leukemia (AML), pediatric leukemia, and myelodysplastic syndromes indications; and Fosciclopirox, a pro-drug of ciclopirox for AML. Notable Labs, Ltd. is headquartered in Foster City, California.

Advanced Technical Analysis

Technical Analysis of NTBL 2024-10-23

The stock indicators reflect a bearish sentiment, with the Moving Average Score at 3, Oscillators Score at 36, and a Technical Score of 20, indicating overall weakness in price momentum and suggesting caution for potential investors. The low scores across all categories highlight a lack of bullish signals in the current market environment.

Technical Scores and Rating

Moving Average Score

Oscillator Score

Technical Rating

Stock Analysis of NTBL

Stock Rank

Recent News & Updates

2024-08-28 19:30
Notable Labs to Present Data on September 4th at SOHO 2024(Globenewswire)
2024-08-26 04:05
Notable Labs Announces CEO Transition(Globenewswire)
2024-08-16 08:53
NTBL Stock Earnings: Notable Labs Misses EPS for Q2 2024(Investorplace)
2024-07-23 19:30
Notable Labs Receives FDA Clearance to Proceed Further with Volasertib Phase 2 Study(Globenewswire)
2024-05-23 21:55
Bears are Losing Control Over Notable Labs (NTBL), Here's Why It's a 'Buy' Now(Zacks)
2024-05-15 23:53
NTBL Stock Earnings: Notable Labs Misses EPS for Q1 2024(Investorplace)
2024-05-12 19:23
Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday(Investorplace)
2024-05-09 04:05
Notable Labs to Participate in Fireside Chat at the Citizens JMP Securities Life Sciences Conference 2024(Globenewswire)
2024-05-09 00:15
Fight Against Pancreatic Cancer Ramps Up as Market Size Revenues Expected to Exceed $36 Billion by 2036(Prnewswire)
2024-04-19 00:00
Notable Labs (NTBL) Upgraded to Buy: What Does It Mean for the Stock?(Zacks)
2024-04-12 01:53
NTBL Stock Earnings: Notable Labs Misses EPS for Q4 2023(Investorplace)
2024-04-11 20:00
Notable Labs Reports 2023 Financial Results and Provides a Business Update(Globenewswire)
2024-04-09 05:15
Notable Labs Presents the Design Plan for the PPMP-Enabled Phase 2 Trial with Volasertib for Relapsed/Refractory AML at AACR 2024(Globenewswire)
2024-04-08 00:00
Notable Labs Presentation of Data Related to Innovations in the Use of Cryopreserved Samples in the PPMP Assay at AACR 2024 Expands the Potential of the Platform(Globenewswire)
2024-03-05 03:35
Notable Labs to Present Two Posters at AACR 2024 on PPMP Platform(Globenewswire)
2024-03-04 15:35
Notable Labs to Present Two Posters at AACR 2024 on PPMP Platform(Globenewswire)
2024-02-21 19:00
Notable Advances Volasertib Phase 2 Program Utilizing Proprietary Predictive Precision Medicine Platform-Guided Enrollment(Globenewswire)
2023-12-17 19:00
Notable Reports Predictive Precision Medicine Platform (PPMP) Accurately Predicted Fosciclopirox Trial Outcome(Globenewswire)
2023-12-12 23:00
Notable Labs Donates $60,000 to MDS Foundation to Accelerate Progress for Patients with Myelodysplastic Syndromes(Prnewswire)
2023-12-10 23:00
Notable Labs Funds Myelodysplastic Syndromes Foundation with $60,000 Grant(Prnewswire)
2023-12-04 03:30
Notable Labs to Participate in JMP Securities Hematology and Oncology Summit(Globenewswire)
2023-11-14 03:15
Notable Labs Announces Filing of Form 10-Q for Third Quarter 2023(Globenewswire)
2023-11-09 03:05
Notable Labs Announces JCO Precision Oncology Publication Demonstrating PPMP Potential to Identify Novel Drug Combinations in JMML(Globenewswire)
2023-10-16 01:01
Notable Labs Closes Merger Transaction With VBL Therapeutics(Globenewswire)
2023-10-11 21:00
VBL Therapeutics Announces Results of Annual and Special Shareholder Meeting(Globenewswire)
2023-10-03 20:00
VBL Therapeutics Reminds Shareholders to Vote in the Upcoming Annual and Special Shareholder Meeting(Globenewswire)
2023-09-05 20:00
VBL Therapeutics Announces that S-4 Registration Statement for Proposed Merger with Notable Labs Is Declared Effective by SEC(Yahoo Finance)
2023-08-13 20:28
Vascular Biogenics: Q2 Earnings Snapshot(Yahoo Finance)
2023-08-13 20:00
VBL Therapeutics Reports Second Quarter 2023 Financial Results and Provides Business Update(Yahoo Finance)
2023-05-15 06:08
Vascular Biogenics: Q1 Earnings Snapshot(Yahoo Finance)

Page 1 of 4

previousnext

Disclaimer: The information provided here and on kavout.com site is for general informational purposes only. It does not constitute investment advice, financial advice, trading advice, or any other sort of advice. Kavout does not recommend that any investment decision be made based on this information. You are solely responsible for your own investment decisions. Please conduct your own research and consult with qualified financial advisors before making any investment. Kavout and its partners are participants in a number of affiliate advertising programs. As an Amazon Associate, Kavout or its partners earn from qualifying purchases from affiliate links. We also participate in other affiliate and advertising programs that provide a means for us to earn advertising fees by advertising and linking to third-party websites.